MUGELLINI, AMEDEO
 Distribuzione geografica
Continente #
NA - Nord America 7.699
EU - Europa 6.127
AS - Asia 6.069
SA - Sud America 501
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
Totale 20.490
Nazione #
US - Stati Uniti d'America 7.561
CN - Cina 3.928
SG - Singapore 1.281
IE - Irlanda 1.166
DE - Germania 1.052
UA - Ucraina 1.019
FI - Finlandia 903
IT - Italia 621
HK - Hong Kong 517
RU - Federazione Russa 472
SE - Svezia 420
BR - Brasile 413
GB - Regno Unito 200
VN - Vietnam 100
CA - Canada 93
FR - Francia 83
IN - India 48
NL - Olanda 48
IQ - Iraq 35
AR - Argentina 33
MX - Messico 30
BD - Bangladesh 24
EC - Ecuador 21
ZA - Sudafrica 21
JP - Giappone 17
ES - Italia 16
RO - Romania 16
BE - Belgio 15
GR - Grecia 15
PL - Polonia 15
EG - Egitto 14
MA - Marocco 14
AT - Austria 13
PK - Pakistan 13
ID - Indonesia 12
KE - Kenya 11
TR - Turchia 11
TH - Thailandia 10
CH - Svizzera 9
CO - Colombia 9
IR - Iran 9
LT - Lituania 9
UZ - Uzbekistan 9
EU - Europa 8
CL - Cile 7
CZ - Repubblica Ceca 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
PE - Perù 6
SI - Slovenia 6
KZ - Kazakistan 5
MU - Mauritius 5
AU - Australia 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LV - Lettonia 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
NP - Nepal 3
TN - Tunisia 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HN - Honduras 2
LB - Libano 2
MD - Moldavia 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
GD - Grenada 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
Totale 20.486
Città #
Chandler 1.382
Jacksonville 1.324
Dublin 1.166
Nanjing 988
Dallas 579
Hong Kong 514
Munich 504
Singapore 467
Boardman 465
Nanchang 452
Ashburn 432
Beijing 428
Princeton 358
Helsinki 307
Shenyang 303
Hebei 291
Lawrence 281
Changsha 265
Wilmington 259
Jiaxing 216
Hangzhou 185
Tianjin 158
Los Angeles 147
Medford 142
Milan 128
Redondo Beach 106
Moscow 91
Buffalo 90
Ann Arbor 74
New York 73
Shanghai 69
Seattle 55
Norwalk 50
Toronto 50
Woodbridge 47
Ho Chi Minh City 44
São Paulo 43
Kunming 35
Turku 29
Pavia 27
Guangzhou 26
Verona 26
Jinan 25
Baghdad 23
Brooklyn 20
Des Moines 19
Rome 19
Santa Clara 19
Ningbo 18
Zhengzhou 18
San Francisco 17
Tokyo 17
Hanoi 16
Magenta 16
Brussels 15
Fairfield 15
Stockholm 15
Chicago 14
Jyväskylä 14
Atlanta 13
Houston 13
Johannesburg 13
Redwood City 13
Lanzhou 12
Montreal 12
Warsaw 12
Phoenix 11
Quito 11
Vienna 11
Chennai 10
Timisoara 10
Vancouver 10
Boston 9
Brasília 9
Dhaka 9
Mexico City 9
Rio de Janeiro 9
Changchun 8
Falls Church 8
Frankfurt am Main 8
Naples 8
Orange 8
Orem 8
Quzhou 8
Tashkent 8
The Dalles 8
Borås 7
Charlotte 7
Council Bluffs 7
Denver 7
Eindhoven 7
Nairobi 7
Pune 7
Ribeirão Preto 7
Tappahannock 7
Turin 7
Washington 7
Belo Horizonte 6
Campinas 6
Dearborn 6
Totale 13.339
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 350
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 267
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 255
Anemia in patients with Covid-19: pathogenesis and clinical significance 255
Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. 236
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 230
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 229
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 137
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 129
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 128
Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria. 114
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 111
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 111
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 108
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients 107
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 107
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 106
Comparison between orlistat and sibutramine in obese patients with mild hypertension 105
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 104
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 102
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 98
Effect of valsartan amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients 98
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 98
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 98
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 97
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 97
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 96
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension 94
Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. 93
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. 93
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. 93
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 93
Adding Losartan to Lisinopril Therapy in Patients with Hypertension: Assessment by 24-hour Ambulatory Blood Pressure Monitoring. 92
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. 91
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 91
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 90
Beta-blockers effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia 90
Effects of Amlodipine, Nifedipine GITS anf Indomethacin on Angiotensin-converting enzyme inhibitor-induced cough: a randomized, placebo-controlled, double-masked croossover study 89
Effect on the development of ankle edema of adding delapril to manidipine inpatients with mild to moderate essential hypertension: a three-way crossoverstudy. 89
Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring 88
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 88
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 88
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 87
Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases 85
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients 85
A double-blind, crossover study of the antihypertensive efficacy of angiotensinII-receptor antagonists and their activation of the renin-angiotensin system. 85
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation 84
Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension 84
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 84
Effect of valsartan on insulin sensitivity and leptin in hypertensive obese patients 84
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 84
Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients:a double-blind, randomized, parallel-group study . 84
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. 84
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 83
Effects of four angiotensin II-receptor antagonists on fibrinolysis in postmenopausal women with hypertension. 83
Aliskiren reduces QT dispersion in hypertensive diabetic patients 83
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 82
Comparison between perindopril and candesartan in hypertensive patients with type 2 diabetes: evaluation of lipid profile and Lp(a) 82
Comparison between repaglinide plus metformin vs glimepiride plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients: a 1 year 82
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 81
Effect of Valsartan and Atenolol on sexual behavior in hypertensive postmenopausal women. 80
Valsartan amlodipine combination and prevention of atrial fibrillation recurrence in hypertensive diabetic patients 80
Effects of valsartan and olmesartan Addition to amlodipine on ankle oedema in hypertensive patients 80
Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring 79
Different effects of aliskiren/hydrochlorotiazide and atenol/hydrochlorotiazide combinations on central pressure in elderly hypertensive patients 79
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients. 79
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. 79
Effetto della combinazione valsartan-amlodipina sulla funzione cognitiva in pazienti ipertesi anziani 79
Comparative Efficacy of Losartan and Valsartan in Mild-to-Moderate Hypertension : results of 24-Hour Ambulatory Blood Pressure Monitoring. 79
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes 78
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 78
Lone paroxysmal atrial fibrillation and inflammatory markers in essential hypertension 78
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 78
Efficacy of Delapril in the treatment of mild to moderate essential hypertension : evaluation by 24-hour ambulatory blood pressure monitoring. 78
Efficacy of fluvastatin together with fenofibrate in hypercholesterolemic type 2 diabetic subjects compared to monotherapy. 78
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 77
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial 77
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 77
Comparison between diet, orlistat and cerivastatin in hypercholesterolemic, obese patients, with mild hypertension 77
Effect of telmisartan and ramipril on arial fibrillation episodes recurrence and severity in hypertensive patients with metabolic syndrome and lone paroxysmal atrial fibrillation 76
Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome 76
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus. 76
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial). 76
Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men 75
Efficacia di fluvastatina e fenofibrato in prevenzione secondaria rispetto alla monoterapia: studio ad 1 anno in pazienti diabetici di tipo 2, ipercolesterolemici 75
Effetti dell'associazione valsartan-amlodipina sui marcatori dell'infiammazione, sullo stress ossidativo e sulla dimetilarginina asimmetrica nei pazienti ipertesi con diabete di tipo 2 75
Effects of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. 75
Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients 75
Comparative evaluation of telmisartan and eprosartan effect on insulin sensitivity in hypertensive patients with metabolic syndrome 74
Comparison of benazepril-amlodipine and captopril-thiazide in the management of mild-to-moderate hypertension. 74
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. 74
Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study. 74
Long-term effects of Amlodipine versus Fosinopril on microalbuminuria in elderly hypertensive patients with type 2 Diabetes Mellitus. 74
Effect of Fosinopril on blood pressure, lipid profile and lipoprotein (a) in normotensive patients with type 2 diabetes and microalbuminuria: open-label, uncontrolled study 73
Ketanserin effects on insulin sensitivity in nonobese, nondiabetic hypertensive patients: an evaluation by the euglycemic-hyperinsulinemic clamp technique. 73
Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients 73
Effect of losartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 73
Effects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trial. 73
Comparison between glimepiride plus metformin vs rosiglitazone plus metformin on glucose metabolism and on blood pressure in Type 2 diabetic patients 73
Influence of losartan and atenolol on cognitive function in very elderly hypertensive patients 72
Totale 9.890
Categoria #
all - tutte 84.010
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.010


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.275 0 0 0 0 0 269 12 288 70 294 272 70
2021/20221.057 21 2 49 6 6 15 16 76 65 25 185 591
2022/20233.771 388 218 25 325 485 443 2 240 1.426 46 117 56
2023/20241.097 112 194 38 69 196 250 35 103 14 39 16 31
2024/20253.623 42 314 95 134 67 203 379 415 819 57 307 791
2025/20263.277 562 531 777 614 738 55 0 0 0 0 0 0
Totale 20.598